None listed
Conditions
Interventions
Intervention1: Reversal with neostigmine or suggamadex: Patients will be reversed with either neostigmine or suggamadex and their post operative pupillary size assesed
Intervention2: Reversal with neo
Sponsors
Sarthak pal
Eligibility
Inclusion criteria
Inclusion criteria: All ASA1 and ASA2 patient undergoing elective surgery
Exclusion criteria
Exclusion criteria: Patients undergoing neurological or ophthalmic surgery on any cardiac medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparing the pupillary size 20 minutes post reversalTimepoint: 20 minutes post reversal | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparing the pupillary reactivity 20 minutes post reversalTimepoint: 20 minutes post reversal;Comparing the size with preinduction and 1 hour post relaxant valuesTimepoint: ;Comparing the incidence of PONV in both groupsTimepoint: ;Comparing the incidence of adverse events(hypotension,bradyarrythmias tachyarrythmias respiratory difficulties)in both groupsTimepoint: | — |
Countries
India
Contacts
Public ContactAmarjyoti Hazarika
Post graduate institute of medical Education and Research,Chandigarh
Outcome results
None listed